NEW YORK, Nov. 7 – Lion Bioscience is ready to close two large i-Biology partnerships in the coming months and has set its sights on a “very promising” potential acquisition target, the company told GenomeWeb.

While Lion would not disclose the names of the companies linked to these partnerships, an analyst said he “suspects” one might be a major California-based pharmaceutical company and the other is likely a top-20 European pharma firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.